Old Web
English
Sign In
Acemap
>
authorDetail
>
Swethajit Biswas
Swethajit Biswas
GlaxoSmithKline
Medicine
Internal medicine
novel agents
Multiple myeloma
Oncology
3
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analysis of cardiac amyloidosis progression using model-based markers
2020
Frontiers in Physiology
Wenguang Li
Alan Lazarus
Hao Gao
Ana Martinez-Naharro
Marianna Fontana
Philip N. Hawkins
Swethajit Biswas
Robert L. Janiczek
Jennifer Cox
Colin Berry
Dirk Husmeier
Xiaoyu Luo
Show All
Source
Cite
Save
Citations (2)
DREAMM-5 platform trial: Belantamab mafodotin in combination with novel agents in patients with relapsed/refractory multiple myeloma (RRMM).
2020
Journal of Clinical Oncology
Paul G. Richardson
Swethajit Biswas
Beata Holkova
Nicola Jackson
Thelma Netherway
Sofia Paul
Geraldine Ferron-Brady
Anne M. Yeakey
Chris Shelton
Rocio Montes de Oca
Christoph Matthias Ahlers
Marc S. Ballas
Elaine Paul
Ira Gupta
Joanna Opalinska
Katarina Luptakova
Show All
Source
Cite
Save
Citations (6)
Dreamm-5: Platform Trial Evaluating Belantamab Mafodotin (a BCMA-directed Immuno-conjugate) in Combination with Novel Agents in Relapsed or Refractory Multiple Myeloma (RRMM)
2019
Blood
Paul G. Richardson
Swethajit Biswas
Beata Holkova
Nicola Jackson
Thelma Netherway
Weichao Bao
Geraldine Ferron-Brady
Anne M. Yeakey
Chris Shelton
Rocio Montes de Oca
Chris Ahlers
Sonia Franco
Marc S. Ballas
Elaine Paul
Katarina Luptakova
Ira Gupta
Joanna Opalinska
Show All
Source
Cite
Save
Citations (4)
1